- Home
- MTC vs DYAI Comparison
MTC vs DYAI Comparison
Compare MTC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTC
- DYAI
- Stock Information
- Founded
- MTC 2015
- DYAI 1979
- Country
- MTC Hong Kong
- DYAI United States
- Employees
- MTC N/A
- DYAI N/A
- Industry
- MTC Computer Software: Prepackaged Software
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTC Technology
- DYAI Health Care
- Exchange
- MTC Nasdaq
- DYAI Nasdaq
- Market Cap
- MTC 26.4M
- DYAI 30.2M
- IPO Year
- MTC 2019
- DYAI 2004
- Fundamental
- Price
- MTC $0.86
- DYAI $1.16
- Analyst Decision
- MTC
- DYAI Strong Buy
- Analyst Count
- MTC 0
- DYAI 1
- Target Price
- MTC N/A
- DYAI $6.00
- AVG Volume (30 Days)
- MTC 765.2K
- DYAI 139.0K
- Earning Date
- MTC 09-12-2025
- DYAI 11-11-2025
- Dividend Yield
- MTC N/A
- DYAI N/A
- EPS Growth
- MTC N/A
- DYAI N/A
- EPS
- MTC N/A
- DYAI N/A
- Revenue
- MTC $2,675,833.00
- DYAI $4,135,078.00
- Revenue This Year
- MTC N/A
- DYAI $34.23
- Revenue Next Year
- MTC N/A
- DYAI $19.57
- P/E Ratio
- MTC N/A
- DYAI N/A
- Revenue Growth
- MTC 114.77
- DYAI 129.20
- 52 Week Low
- MTC $0.76
- DYAI $0.71
- 52 Week High
- MTC $5.10
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- MTC 42.99
- DYAI 56.82
- Support Level
- MTC $0.80
- DYAI $1.13
- Resistance Level
- MTC $0.88
- DYAI $1.35
- Average True Range (ATR)
- MTC 0.04
- DYAI 0.10
- MACD
- MTC -0.00
- DYAI 0.00
- Stochastic Oscillator
- MTC 37.34
- DYAI 50.16
About MTC MMTec Inc.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.